• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Lumexa Imaging Announces Participation in Upcoming Investor Conferences

    2/17/26 7:30:00 AM ET
    $LMRI
    Medical Specialities
    Health Care
    Get the next $LMRI alert in real time by email

    RALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the following upcoming investor conferences:

    Lumexa Imaging Logo (PRNewsfoto/Lumexa Imaging)

    • Raymond James Institutional Investors Conference, being held in Orlando, Florida, including a presentation at 3:25pm EST on Monday, March 2, 2026.
    • Leerink Partners Global Healthcare Conference, being held in Miami, Florida, including a fireside chat at 8:40am EST on Monday, March 9, 2026.
    • Barclays 28th Annual Global Healthcare Conference, being held in Miami, Florida, including a fireside chat at 3:30pm EST on Tuesday, March 10, 2026.

    A webcast link and related presentation materials, if applicable, will be available online at https://ir.lumexaimaging.com.

    ABOUT LUMEXA IMAGING

    Lumexa Imaging (NASDAQ:LMRI) is a nationwide provider of outpatient medical imaging. With over 5,000 team members and more than 185 outpatient imaging centers across 13 states, our team conducted approximately 4 million outpatient scans in 2024. We are a partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform.

    INVESTOR CONTACT

    ICR Healthcare

    ir@lumexaimaging.com

    MEDIA CONTACT

    Melissa Weston

    corpcomms@lumexaimaging.com

    Forward-Looking Statements

    Certain statements contained in this press release are forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact contained in this press release are forward-looking statements, including statements regarding our business strategy, plans and objectives of management for future operations and any discussions at the investor conferences described above. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

    In some cases, you can identify forward-looking statements by terms such as "may," "would," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, results of operations, and liquidity. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. 

    Forward-looking statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lumexa-imaging-announces-participation-in-upcoming-investor-conferences-302688936.html

    SOURCE Lumexa Imaging

    Get the next $LMRI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LMRI

    DatePrice TargetRatingAnalyst
    2/9/2026$23.00Outperform → Strong Buy
    Raymond James
    1/5/2026$23.00Overweight
    Analyst
    1/5/2026$23.00Buy
    Jefferies
    1/5/2026$22.00Overweight
    Wells Fargo
    1/5/2026Outperform
    William Blair
    1/5/2026$23.00Outperform
    Raymond James
    1/5/2026$23.00Outperform
    Leerink Partners
    1/5/2026$22.00Buy
    Deutsche Bank
    More analyst ratings

    $LMRI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Brodnax Brett bought $253,750 worth of shares (35,000 units at $7.25), increasing direct ownership by 130% to 62,027 units (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    5/21/26 4:20:16 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Director Cooper Henry Lee bought $223,113 worth of shares (30,000 units at $7.44) (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    5/18/26 4:12:52 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Principal Accounting Officer Walker James Edward Jr. was granted 12,414 shares, increasing direct ownership by 252% to 17,346 units (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    2/27/26 5:40:01 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    SEC Filings

    View All

    SEC Form 10-Q filed by Lumexa Imaging Holdings Inc.

    10-Q - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    5/12/26 4:15:47 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    5/12/26 4:08:46 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form DEFA14A filed by Lumexa Imaging Holdings Inc.

    DEFA14A - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    4/28/26 4:37:06 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York

    RALEIGH, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the formation of a strategic joint venture with Hospital for Special Surgery (HSS), world leader in musculoskeletal health. The collaboration represents Lumexa Imaging's ninth joint venture and further strengthens the company's presence in New York—one of the nation's largest healthcare markets. Lumexa Imaging and HSS plan to expand access to advanced outpatient imaging services across the New York City metro area, bringing high-quality, convenient care closer to patients and referring providers. This announcement reflects co

    6/2/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Announces First Quarter 2026 Results

    RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 guidance.  "In Q1, we delivered several meaningful achievements to kick off a year of executing on our strategic priorities," said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. "We continued to drive strong growth in same-center advanced imaging volumes and our de novo centers are ramping according to our plans." "We are also announcing tonight four additional Lumexa Imaging centers including two strategic tuck-in acquisitions plus tw

    5/12/26 4:07:00 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers

    RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the addition of four new locations in 2026 as part of its continued execution against a disciplined, multi-channel growth strategy. The new centers are located in Spartanburg, South Carolina; Concord, North Carolina; Wexford, Pennsylvania; and Niceville, Florida. Two of the new locations were added through acquisitions with Lumexa Imaging's joint venture partners, Advocate Health and UPMC, further advancing Lumexa Imaging's strategy to expand in high-growth markets through partnerships with leading health systems. With these tw

    5/12/26 4:05:00 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lumexa Imaging Holdings upgraded by Raymond James with a new price target

    Raymond James upgraded Lumexa Imaging Holdings from Outperform to Strong Buy and set a new price target of $23.00

    2/9/26 8:16:45 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Analyst initiated coverage on Lumexa Imaging Holdings with a new price target

    Analyst initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $23.00

    1/5/26 9:16:52 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Jefferies initiated coverage on Lumexa Imaging Holdings with a new price target

    Jefferies initiated coverage of Lumexa Imaging Holdings with a rating of Buy and set a new price target of $23.00

    1/5/26 8:58:21 AM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Brodnax Brett bought $253,750 worth of shares (35,000 units at $7.25), increasing direct ownership by 130% to 62,027 units (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    5/21/26 4:20:16 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Director Cooper Henry Lee bought $223,113 worth of shares (30,000 units at $7.44) (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    5/18/26 4:12:52 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Leadership Updates

    Live Leadership Updates

    View All

    Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

    RALEIGH, N.C., April 20, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the appointment of Kyle Lynch as its new Chief Growth Officer (CGO). Lynch joins the executive leadership team to lead the company's enterprise growth strategy, with responsibility for expanding Lumexa Imaging's platform through joint ventures, acquisitions, and de novo development. In this role, Lynch will oversee the full growth lifecycle, including opportunity origination, transaction execution, and post-close value realization, with a focus on driving sustainable, profitable growth and maximizing return on invested capita

    4/20/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    $LMRI
    Financials

    Live finance-specific insights

    View All

    Lumexa Imaging Announces First Quarter 2026 Results

    RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 guidance.  "In Q1, we delivered several meaningful achievements to kick off a year of executing on our strategic priorities," said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. "We continued to drive strong growth in same-center advanced imaging volumes and our de novo centers are ramping according to our plans." "We are also announcing tonight four additional Lumexa Imaging centers including two strategic tuck-in acquisitions plus tw

    5/12/26 4:07:00 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date

    RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET. The live audio webcast will be available in the Investor Relations section of the Company's website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one year. About Lumexa Imaging Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team member

    4/28/26 4:15:00 PM ET
    $LMRI
    Medical Specialities
    Health Care